PAREXEL International Corporation is a biopharmaceutical services company that supports the pharmaceutical, biotechnology, and medical device industries globally. Founded in 1983 and headquartered in Waltham, Massachusetts, PAREXEL offers a wide range of services through three main segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics. The CRS segment specializes in managing clinical trials, including study design, patient enrollment, data management, and pharmacovigilance. The PCMS segment provides consulting services in drug development, regulatory affairs, and market access, assisting clients with product launch strategies and reimbursement issues. Additionally, the Perceptive segment offers technology solutions such as medical imaging, data management systems, and patient engagement applications. By delivering comprehensive expertise in clinical research and commercialization, PAREXEL facilitates scientific discoveries and the development of new treatments.
The Medical Affairs Company LLC, based in Kennesaw, Georgia, is a contract medical organization that delivers a range of medical and scientific affairs solutions to the pharmaceutical, biotechnology, and medical device industries. Founded in 2007, it specializes in medical science liaison (MSL) programs, MSL training, and medical communications support. The company offers tools such as mslConnect for MSL field intelligence, MSL Academy for training, and i-MSL for web-based clinical consultations. In addition, it provides services including pharmacovigilance, medical writing, peer-to-peer scientific interaction, and support for medical meetings. With a workforce of approximately 200 employees, The Medical Affairs Company operates as a subsidiary of PAREXEL International Corporation and has established a strategic alliance with PDI, Inc.
ExecuPharm Inc. operates as a functional service contract research organization (CRO) in the United States and internationally. The company focuses on providing functional services for the biopharmaceutical industry. It offers CRO support services, which include clinical trial management, monitoring and site management, clinical trial administration, document management, contract and grants management, medical writing, regulatory, and vendor oversight services. The company also provides functional and cross functional resourcing and outsourcing services, which include hybrid resourcing and outsourcing; cross-functional outsourcing; and functional outsourcing, which include clinical trial management, monitoring and site management, clinical trial administration, contract and grants management, data management, biostatistics, drug safety, medical writing, regulatory, and vendor and CRO oversight services. In addition, it offers traditional resourcing services. ExecuPharm Inc. was founded in 1995 and is based in King Of Prussia, Pennsylvania. It has locations in Nova Scotia, Canada; Mexico City, Mexico; Buenos Aries, Argentina; Chichester, United Kingdom; Bengaluru, India; Shanghai, China; and Tokyo, Japan. As of October 3, 2016, ExecuPharm Inc. operates as a subsidiary of PAREXEL International Corporation.
Health Advances, LLC provides strategy consulting services, such as development of commercialization strategies for products and services for the healthcare industry in the United States and internationally. The company offers services in the areas of autoimmune disease, cardio and peripheral vascular diseases, CNS diseases, dermatology and wound care, genitourinary diseases, infectious diseases, oncology and hematology, ophthalmology and otolaryngology, orthopedics, respiratory conditions, and women's health; diabetes, obesity, and endocrine diseases; and diagnostic lab services, personalized medicine, respiratory conditions, and traditional lab/point of care diagnostics. It also provide services in various areas, such as clinical development strategy, due diligence, launch and sales force strategy, M&A strategy and due diligence, business strategy, lifecycle management, market assessment and forecasting, partnering and licensing, portfolio planning, reimbursement and pricing strategy, product positioning, strategic and business planning, technology commercialization, and valuation and financial analysis. It serves clients in biopharma, medtech, diagnostics and life science tools, health IT, and service businesses. Health Advances, LLC was founded in 1992 and is headquartered in Weston, Massachusetts with additional offices Boston, San Francisco, and Washington, D.C.; and Zug, Switzerland. As of February 10, 2016, Health Advances, LLC operates as a subsidiary of PAREXEL International Corporation.
Quantum Solutions India
Acquisition in 2015
Quantum Solutions India was established in 2004, and delivers a complete range of pharmacovigilance services including individual case safety report processing, brand physician activities, affiliate support, aggregate report writing, literature reviews, and signal detection. The Company serves pharmaceutical, medical device and consumer clients across the globe, and has approximately 900 employees.
ClinIntel Ltd.
Acquisition in 2014
ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
ATLAS Medical Services, Ltd.
Acquisition in 2014
ATLAS provides services across all phases of clinical development and has therapeutic expertise in Oncology, Hematology, Endocrinology, Cardiovascular, Anesthesiology, Infectious Diseases and the Central Nervous System. The firm also provides clinical trial-related services from study planning and feasibility, through site selection, data management and medical writing. ATLAS also provides regulatory services and can support product registration. - See more at: https://www.parexel.com/organization/news-events/press-releases/2014/parexel-international-announces-acquisition-atlas-medical-services-provider-clinical-research-services-turkey#sthash.mKquI29x.dpuf
HERON Group Ltd.
Acquisition in 2013
HERON Group LTD (“HERON”) is a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. HERON has expertise and methodologies spanning a wide range of services, including strategic market access planning, systematic reviews, economic modeling and evaluation, pricing, reimbursement strategies, global value dossier writing, and engagement with Health Technology Assessment authorities.
Liquent, Inc. offers content assembly and publishing solutions tailored for the life sciences industry. Its primary products include CoreDossier, which manages compliance information; kPublisher, used for preparing reports and documents; kPortal, a web-based platform for managing publications; Liquent Xtent, a middleware solution that transforms business information into easily distributable formats; and ExSource Solution, which provides consulting and outsourcing services for publishing needs. Liquent serves a diverse clientele comprising pharmaceutical manufacturers, biotechnology firms, medical device companies, veterinary medicine, agrochemicals, generic drug producers, government agencies, and industries related to food and cosmetics. Founded in 1994 as Electronic Submission Publishing Systems, Inc., the company rebranded to Liquent, Inc. in 2001 and is headquartered in Fort Washington, Pennsylvania. It operates as a subsidiary of Thomson Reuters Corporation.
ClinPhone is the clinical technology organizations. With headquarters in Nottingham, United Kingdom.
PAREXEL APEX International Co., Ltd.
Acquisition in 2007
APEX International Clinical Research Co., Ltd. (“APEX”). APEX providing clients with a wide range of clinical research service offerings throughout the Asia-Pacific region, including mainland China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia.
California Clinical Trials Medical Group, Inc.
Acquisition in 2006
California Clinical Trials Medical Group, Inc. (“CCT”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.
Behavioral and Medical Research LLC
Acquisition in 2006
Behavioral and Medical Research, LLC (“BMR”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.
Perceptive Informatics, Inc.
Acquisition in 2005
Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak.
QdotPharma Ltd.
Acquisition in 2005
QdotPharma is a Phase I and IIa Proof of Concept clinical pharmacology business located in George, South Africa. Established in 1996, the privately held company operates 32 beds and has therapeutic expertise in working with drugs to treat central nervous system, psychiatric, cardiovascular, and metabolic conditions.
Integrated Marketing Concepts
Acquisition in 2004
Integrated Marketing Concepts specializes in clinical trial patient recruitment and retention, sales lead management, teleservices, call center services, fulfillment, focus group and database management, and market research. IMC serves a diversified client base across a wide array of industries, including pharmaceutical and biotechnology companies, and drug manufacturers. The Company employs approximately 50 individuals at its headquarters in Whitehall, PA.
3ClinicalResearch AG
Acquisition in 2004
3ClinicalResearch AG (“3C”) is a clinical research organization. The privately held company based in Berlin, Germany.
FW Pharma Systems Ltd.
Acquisition in 2003
FW Pharma Systems Ltd., is a software company that delivers enterprise-wide clinical trial management systems (CTMS). The privately held company is based in Birmingham, United Kingdom.
Pracon & HealthIQ
Acquisition in 2002
Pracon & HealthIQ provides services to pharmaceutical, biotech, and medical device companies in the areas of reimbursement assistance services, communications, and competitive intelligence. Founded in 1976.
Invantage, Inc.
Acquisition in 2002
Established in 1994, Invantage has focused on the development of solutions that expedite clinical study start-up via a portfolio of advanced software applications and associated services. Invantage’s flagship product, the Investigator DataWeb Enterprise Edition, is a sophisticated web-based data repository of potential clinical investigators combined with a decision support environment for initiating clinical trials. The product was developed in conjunction with a number of major pharmaceutical companies.
EDYABE
Acquisition in 2001
EDYABE is a clinical research organization in Latin America located in Argentina and Brazil.
FARMOVS PAREXEL (Proprietary) Ltd.
Acquisition in 2000
FARMOVS-PAREXEL is an established pharmacology research unit and bioanalytical laboratory dedicated to performing clinical pharmacology studies. Trials conducted at this unit include, but are not limited to, proof-of-concept, drug interaction, single and multiple dose, specialized PK/PD and biomarker, glucose clamp, spiro-ergometry, and recombinant vaccine studies. It is a part of the PAREXEL Clinical Pharmacology Network that includes Clinical Pharmacology Research Units in Baltimore, Maryland; Berlin, Germany; London, United Kingdom and bioanalytical laboratories in Bloemfontein and Poitiers, France offering more than 500 validated assay methods.
CEMAF SA
Acquisition in 1999
CEMAF S.A., is a Phase I clinical research and bioanalytical laboratory located in Poitiers, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.